Elevated X-linked inhibitor of apoptosis protein (XIAP) expression uncovers detrimental prognosis in subgroups of neoadjuvant treated and T-cell rich esophageal adenocarcinoma

BACKGROUND: Molecular markers predicting survival in esophageal adenocarcinoma (EAC) are rare. Specifically, in favorable oncologic situations, e.g. nodal negativity or major neoadjuvant therapy response, there is a lack of additional risk factors that serve to predict patients’ outcome more precise...

Descripción completa

Detalles Bibliográficos
Autores principales: Schiffmann, Lars M., Göbel, Heike, Löser, Heike, Schorn, Fabian, Werthenbach, Jan Paul, Fuchs, Hans F., Plum, Patrick S., Bludau, Marc, Zander, Thomas, Schröder, Wolfgang, Bruns, Christiane J., Kashkar, Hamid, Quaas, Alexander, Gebauer, Florian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6545033/
https://www.ncbi.nlm.nih.gov/pubmed/31151416
http://dx.doi.org/10.1186/s12885-019-5722-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6545033/
https://www.ncbi.nlm.nih.gov/pubmed/31151416
http://dx.doi.org/10.1186/s12885-019-5722-1

Ejemplares similares